HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hillhouse Capital Related

510.843

-19.317-3.64%

Number of Gainers:8

Number of Losers:43

Number of Flat:4

PE:- -

High:530.970

Open:530.107

Low:506.286

Close:530.160

Loading ...

Everest Medicines Shares Surge 18% as First Patient Dosed in Cancer Drug Trial

MT Newswires Live

BeiGene Commences New Offering Period for Employee Share Purchase Plan

MT Newswires Live

MicroPort CardioFlow to Narrow Losses in 2024; Shares Rise 7%

MT Newswires Live

Why Investors Shouldn't Be Surprised By Peijia Medical Limited's (HKG:9996) 31% Share Price Surge

Simply Wall St.

BRIEF-Microport Cardioflow Medtech Sees FY Net Loss RMB30 Million To RMB60 Million

Microport Cardioflow Medtech - Expected Result Due to Fair Value Gains on Convertible Instruments Issued by 4C Medical in FY, Others

THOMSON REUTERS

Microport Cardioflow Medtech Sees FY Net Loss RMB30 Mln to RMB60 Mln

THOMSON REUTERS

JD Health International Logs 94% Higher Attributable Profit for 2024

MT Newswires Live

BRIEF-JD Health International Posts FY Revenue Of RMB 58,200 Million

JD Health International FY Gross Margin 22.9%

THOMSON REUTERS

Hong Kong Stocks Surge on Arisen Expectations for Forceful Stimulus; Peijia Medical, HBM Surge Over 12%

MT Newswires Live

Everest Medicines Announces First Patient Dosed With Evm16, Its First Internally Developed Personalized Mrna Cancer Vaccine

THOMSON REUTERS

Everest Medicines Ltd - Evm16 Shows Synergistic Effect With Pd-1 Antibody in Preclinical Data

THOMSON REUTERS

Everest Medicines Ltd - Evm16 Well Tolerated and Safe in Preclinical Toxicity Studies

THOMSON REUTERS

HBM Holdings Receives Upfront Payment, Stake for Immunological Diseases Antibody

MT Newswires Live

Peijia Medical Completes First Two Implants with Transcatheter System; Shares Up 8%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/BK1583/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1583"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":510.84283,"timestamp":1741594084374,"preClose":530.16,"halted":0,"volume":641110353,"delay":0,"changeRate":-0.036436,"change":-19.317139,"pbRate":2.561308,"amount":16897837474.6,"amplitude":0.04656,"prevYearClose":446.93042,"fiveDayClose":491.838,"twentyDayClose":478.478,"turnoverRate":0.004545,"marketCap":2846829146368,"floatMarketCap":2260124340224,"peRate":34.961436},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":530.9704,"amplitude":0.04656,"preClose":530.16,"low":506.28616,"pbRate":"2.561308","latestPrice":510.84283,"volume":641110353,"delay":0,"open":530.1071,"prevYearClose":446.93042,"prevWeekClose":530.16,"prevMonthClose":492.906,"prevQuarterClose":446.93,"fiveDayClose":491.838,"twentyDayClose":478.478,"sixtyDayClose":472.845,"secType":"PLATE","market":"HK","turnoverRate":0.004545,"peRate":34.961436,"marketCap":2846829146368,"floatMarketCap":2260124340224,"timestamp":1741594084374,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":8,"down":43,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:16,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517179442","title":"Everest Medicines Shares Surge 18% as First Patient Dosed in Cancer Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2517179442","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517179442?lang=en_us&edition=fundamental","pubTime":"2025-03-07 15:50","pubTimestamp":1741333820,"startTime":"0","endTime":"0","summary":"Everest Medicines  said the first patient was dosed in a clinical trial of its mRNA cancer vaccine EVM16 at Peking University Cancer Hospital,The study aims to assess the safety, tolerability, immunogenicity, and preliminary efficacy of EVM16 as a monotherapy and in combination with a PD-1 antibody in advanced or recurrent solid tumors.The clinical trial of EVM16 is being conducted jointly at Peking University Cancer Hospital and Fudan University Shanghai Cancer Center, according to a Thursday news release.Shares of the biopharmaceutical company soared 18% in recent trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01952","BK1161","BK1574","BK1583","MDCO"],"gpt_icon":0},{"id":"2517175550","title":"BeiGene Commences New Offering Period for Employee Share Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2517175550","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517175550?lang=en_us&edition=fundamental","pubTime":"2025-03-07 15:26","pubTimestamp":1741332372,"startTime":"0","endTime":"0","summary":"BeiGene  said a new offering period for its 2018 employee share purchase plan started on Monday and will last until Aug. 29, 2025.1% to 10% of the payrolls of the eligible employees will be deducted during the offering period and will be used at the end of the offering period to purchase shares, including American depository shares, a Thursday Hong Kong bourse filing said.The share purchase plan offers a 15% discount to the 4,218 eligible employees.The enrollment period for the offering was from Feb. 17 to Feb. 28.The closing price of the shares on Monday, the first day of the offering period, was $245.53 per American depository share.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["688235","LU0307460666.USD","06160","LU1969619763.USD","BK1161","LU2328871848.SGD","LU0588546209.SGD","BK1500","BK1588","BK0239","BK1583"],"gpt_icon":0},{"id":"2517122378","title":"MicroPort CardioFlow to Narrow Losses in 2024; Shares Rise 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517122378","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517122378?lang=en_us&edition=fundamental","pubTime":"2025-03-07 13:58","pubTimestamp":1741327136,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow Medtech  expects a net loss of between 30 million yuan and 60 million yuan in 2024, representing a decline of 87% to 94% from a year prior, according to a Thursday filing.The medical device maker attributed the forecast to the advancement of commercialization of certain products, higher overseas revenue, cost management, reversal of an impairment loss on an equity investment, and fair value gains on convertible instruments.Shares of the company were up 7% in recent trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1100","BK1574","BK1583","02160"],"gpt_icon":0},{"id":"2517120012","title":"Why Investors Shouldn't Be Surprised By Peijia Medical Limited's (HKG:9996) 31% Share Price Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2517120012","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517120012?lang=en_us&edition=fundamental","pubTime":"2025-03-07 07:00","pubTimestamp":1741302017,"startTime":"0","endTime":"0","summary":"Peijia Medical Limited ( HKG:9996 ) shares have had a really impressive month, gaining 31% after a shaky period...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-9996/peijia-medical-shares/news/why-investors-shouldnt-be-surprised-by-peijia-medical-limite-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","BK1574","BK1100","BK1583","BK4211","09996"],"gpt_icon":1},{"id":"2517169811","title":"BRIEF-Microport Cardioflow Medtech Sees FY Net Loss RMB30 Million To RMB60 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517169811","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517169811?lang=en_us&edition=fundamental","pubTime":"2025-03-06 23:05","pubTimestamp":1741273502,"startTime":"0","endTime":"0","summary":"BRIEF-Microport Cardioflow Medtech Sees FY Net Loss RMB30 Million To RMB60 MillionMarch 6  - Microport Cardioflow Medtech Corp 2160.HK:SEES FY NET LOSS RMB30 MILLION TO RMB60 MILLIONEXPECTED RESULT DUE TO FAIR VALUE GAINS ON CONVERTIBLE INSTRUMENTS ISSUED BY 4C MEDICAL IN FY, OTHERSFurther company coverage: 2160.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP022:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02160","BK1574","BK1583"],"gpt_icon":0},{"id":"2517501871","title":"Microport Cardioflow Medtech - Expected Result Due to Fair Value Gains on Convertible Instruments Issued by 4C Medical in FY, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2517501871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517501871?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:53","pubTimestamp":1741269200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP022:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1583","BK1100","02160"],"gpt_icon":0},{"id":"2517150180","title":"Microport Cardioflow Medtech Sees  FY Net Loss RMB30 Mln to RMB60 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2517150180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517150180?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:53","pubTimestamp":1741269200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP022:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02160","BK1100","BK1574","BK1583"],"gpt_icon":0},{"id":"2517130577","title":"JD Health International Logs 94% Higher Attributable Profit for 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2517130577","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517130577?lang=en_us&edition=fundamental","pubTime":"2025-03-06 18:41","pubTimestamp":1741257711,"startTime":"0","endTime":"0","summary":"JD Health International  recorded a profit attributable to the owners of 4.16 billion yuan in 2024, 94% higher than 2.14 billion yuan from 2023, a Thursday Hong Kong bourse filing said.The earnings per share were 1.32 yuan, compared with 0.68 yuan per share from a year earlier.The digital health services company's revenue for the year came in at 58.2 billion yuan, 8.6% higher than 53.5 billion yuan of the preceding year.The increase in revenue is attributed to an increase in revenue from the sales of pharmaceutical and healthcare products resulting from an increase in active user accounts, additional purchases, and the increase in online product sales.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4503","IE0008368742.USD","LU1688375341.USD","BK1571","BK4220","BK4585","LU1188198961.HKD","LU0051755006.USD","BK1142","BK4505","LU0456827905.SGD","86618","BK4526","BK4524","IE00BGV7N243.SGD","BK1591","BK4509","BK1589","LU0106959298.USD","BK4504","BK4531","SG9999002463.SGD","LU0326950275.SGD","LU0463099449.HKD","BK1583","BK4579","BK1515","LU0588546209.SGD","06618","BK4122","LU0244354667.USD","BK4551","LU0307460666.USD","LU1880383366.USD","BK4558","BK1247","BK4588"],"gpt_icon":1},{"id":"2517132001","title":"BRIEF-JD Health International Posts FY Revenue Of RMB 58,200 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517132001","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517132001?lang=en_us&edition=fundamental","pubTime":"2025-03-06 18:13","pubTimestamp":1741256017,"startTime":"0","endTime":"0","summary":"BRIEF-JD Health International Posts FY Revenue Of RMB 58,200 MillionMarch 6  - JD Health International Inc 6618.HK:FY NET INCOME RMB 4,200 MILLIONFY REVENUE RMB 58,200 MILLIONFY GROSS MARGIN 22.9%FY GROSS PROFIT RMB 13,300 MILLIONFurther company coverage: 6618.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nPLXEEAEF7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1142","BK1515","BK1589","86618","LU0051755006.USD","BK1583","LU0456827905.SGD","BK1591","BK1247","06618","BK1571"],"gpt_icon":0},{"id":"2517340136","title":"JD Health International FY Gross Margin 22.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517340136","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517340136?lang=en_us&edition=fundamental","pubTime":"2025-03-06 17:00","pubTimestamp":1741251659,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nPLXEEAEF7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1247","LU0051755006.USD","BK1515","86618","06618","BK1591","BK1583","BK1589","BK1142","LU0456827905.SGD","BK1571"],"gpt_icon":0},{"id":"2517135443","title":"Hong Kong Stocks Surge on Arisen Expectations for Forceful Stimulus; Peijia Medical, HBM Surge Over 12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517135443","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517135443?lang=en_us&edition=fundamental","pubTime":"2025-03-06 16:55","pubTimestamp":1741251351,"startTime":"0","endTime":"0","summary":"Hong Kong stocks hit an almost three-year high, erasing any losses driven by the trade war with the U.S. on the arisen expectations that Beijing will introduce more stimulus to achieve the growth targ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HHImain","BK1583","02833","BK1574","02142","BK1100","BK1161","09996","513600","MCHmain","HSI"],"gpt_icon":1},{"id":"2517813874","title":"Everest Medicines Announces First Patient Dosed With Evm16, Its First Internally Developed Personalized Mrna Cancer Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2517813874","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517813874?lang=en_us&edition=fundamental","pubTime":"2025-03-06 16:30","pubTimestamp":1741249803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nTUA99ZLJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","BK1583","01952"],"gpt_icon":0},{"id":"2517613870","title":"Everest Medicines Ltd - Evm16 Shows Synergistic Effect With Pd-1 Antibody in Preclinical Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2517613870","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517613870?lang=en_us&edition=fundamental","pubTime":"2025-03-06 16:30","pubTimestamp":1741249803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nTUA99ZLJF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","01952","BK1574","BK1161"],"gpt_icon":0},{"id":"2517138709","title":"Everest Medicines Ltd - Evm16 Well Tolerated and Safe in Preclinical Toxicity Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2517138709","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517138709?lang=en_us&edition=fundamental","pubTime":"2025-03-06 16:30","pubTimestamp":1741249803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nTUA99ZLJF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","01952","BK1574","BK1161"],"gpt_icon":0},{"id":"2517185660","title":"HBM Holdings Receives Upfront Payment, Stake for Immunological Diseases Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2517185660","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517185660?lang=en_us&edition=fundamental","pubTime":"2025-03-06 14:40","pubTimestamp":1741243252,"startTime":"0","endTime":"0","summary":"HBM Holdings  received an upfront payment for its licensing agreement with Windward Bio AG, along with an equity interest in the latter's parent company, a Thursday Hong Kong bourse filing said.The company and Sichuan Kelun-Biotech Biopharmaceutical  had agreed to grant an exclusive license for their jointly developed HBM9378/SKB378, an anti-TSLP fully human antibody for immunological diseases, to Windward Bio, which could commercialize the drug worldwide aside from greater China and some other Southeast and West Asian countries.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","06990","BK1583","02142","LU0196878994.USD","BK1574"],"gpt_icon":0},{"id":"2517002889","title":"Peijia Medical Completes First Two Implants with Transcatheter System; Shares Up 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517002889","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517002889?lang=en_us&edition=fundamental","pubTime":"2025-03-06 13:50","pubTimestamp":1741240218,"startTime":"0","endTime":"0","summary":"Peijia Medical  has completed the first two implants with the TrilogyTM Transcatheter Heart Valve System to treat severe aortic regurgitation in Taiwan, China, a Wednesday filing with the Hong Kong bourse said.The system is indicated for use in patients with symptomatic severe aortic regurgitation or symptomatic severe aortic stenosis who are at high risk for surgical aortic valve replacement.Shares of the company were up over 8% in recent trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09996","BK1583","BK1574","BK1100"],"gpt_icon":0}],"pageSize":16,"totalPage":6,"pageCount":2,"totalSize":83}]}}